SARS-CoV-2 Nucleocapsid 抗体
(11 references)-
- 抗原 See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) 抗体
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
适用
- SARS Coronavirus-2 (SARS-CoV-2)
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This SARS-CoV-2 Nucleocapsid antibody is un-conjugated
-
应用范围
- ELISA, Western Blotting (WB), Immunofluorescence (IF)
- 特异性
- Specific for the nucleoprotein of the SARS virus.
- 纯化方法
- SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleoprotein antibody is purified from ascites fluid or culture medium by protein A chromoatography or sequential differential precipitations.
- 克隆位点
- 3851
- 亚型
- IgG2b
- Top Product
- Discover our top product SARS-CoV-2 N Primary Antibody
-
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) antibody
SARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2), Virus ELISA, WB 宿主: 小鼠 Monoclonal 1C7 unconjugated
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) (AA 1-419) antibody (Fc Tag)SARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA, WB, GICA 宿主: HEK-293 Cells Chimeric 1A6 Fc Tag scFv fragment Recombinant Antibody
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV) ELISA, IF 宿主: 兔 Chimeric CR3018 (03-018) unconjugated Recombinant Antibody
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA, WB, GICA 宿主: 小鼠 Monoclonal 3C6 unconjugated
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) (AA 1-419) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA, GICA 宿主: Human Chimeric 1A6 unconjugated scFv fragment Recombinant Antibody
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) (AA 1-419) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2), Virus ELISA, WB 宿主: 兔 Polyclonal unconjugated
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) (AA 1-419) antibody (HRP)SARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA 宿主: Human Monoclonal 1A6 HRP scFv fragment Recombinant Antibody
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA 宿主: 兔 Monoclonal DM22 unconjugated
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) (C-Term) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) WB 宿主: 山羊 Polyclonal unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- phosphate saline buffer (0.01M, pH 7.2) containing 0.1 % sodium azide preservative. No stabilizing proteins have been added.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- antibody can be stored at -20°C, stable for one year.
- 有效期
- 12 months
-
-
: "Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection." in: PloS one, Vol. 18, Issue 2, pp. e0281281, (2023) (PubMed).
: "Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Issue 30, pp. e2221809120, (2023) (PubMed).
: "Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern." in: Journal of dairy science, (2022) (PubMed).
: "Identification of cell type specific ACE2 modifiers by CRISPR screening." in: PLoS pathogens, Vol. 18, Issue 3, pp. e1010377, (2022) (PubMed).
: "ARF6 is an important host factor for SARS-CoV-2 infection in vitro." in: bioRxiv : the preprint server for biology, (2022) (PubMed).
: "In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment." in: bioRxiv : the preprint server for biology, (2022) (PubMed).
: "Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is required for SARS-CoV-2 infection in circulating monocytes." in: Cell discovery, Vol. 8, Issue 1, pp. 89, (2022) (PubMed).
: "In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment." in: Vaccines, Vol. 10, Issue 8, (2022) (PubMed).
: "Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Issue 36, (2021) (PubMed).
: "Prolonged SARS-CoV-2 replication in an immunocompromised patient." in: The Journal of infectious diseases, (2020) (PubMed).
: "Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19." in: bioRxiv : the preprint server for biology, (2020) (PubMed).
-
: "Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection." in: PloS one, Vol. 18, Issue 2, pp. e0281281, (2023) (PubMed).
-
- 抗原
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
- 别名
- SARS-CoV-2 Nucleocapsid Protein (SARS-CoV-2 N 产品)
- 物质类
- Viral Protein
-
